Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial
<p>Abstract</p> <p>Background</p> <p>Reducing low-density lipoprotein cholesterol (LDL-C) is associated with reduced risk for major coronary events. Despite statin efficacy, a considerable proportion of statin-treated hypercholesterolemic patients fail to reach therapeu...
Main Authors: | Yu Chih-Chieh, Lai Wen-Ter, Shih Kuang-Chung, Lin Tsung-Hsien, Lu Chieh-Hua, Lai Hung-Jen, Hanson Mary E, Hwang Juey-Jen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1756-0500/5/251 |
Similar Items
-
Assessing the Interactions of Statins with Human Adenylate Kinase Isoenzyme 1: Fluorescence and Enzyme Kinetic Studies
by: Magdalena Wujak, et al.
Published: (2021-05-01) -
Combined Effect of Diosgenin Along with Ezetimibe or Atorvastatin on the Fate of Labelled Bile Acid and Cholesterol in Hypercholesterolemic Rats
by: Alejandro Marín-Medina, et al.
Published: (2019-02-01) -
Beyond confusion and controversy, can we evaluate the real efficacy and safety of cholesterol-lowering with statins?
by: Michel de Lorgeril, et al.
Published: (2016-01-01) -
Sulfonated PEEK-statins delivery system enhances bone repair in mice with skull defect
by: LYU Dan, et al.
Published: (2020-10-01) -
Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study
by: Hing Ling Paul, et al.
Published: (2012-01-01)